🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Please come and join our faculty Lara Hathout presenting #ASTRO2022 ASTRO Rutgers Radiation Oncology Residency Program Rutgers Cancer Institute

Please come and join our chair Bruce Haffty moderating #ASTRO2022 ASTRO Rutgers Radiation Oncology Residency Program Rutgers Cancer Institute Rutgers RWJMedSchool Rutgers New Jersey Medical School

Please come and join our faculty MDMattes presenting in multidisciplinary cancer care #ASTRO2022 ASTRO Rutgers Radiation Oncology Residency Program Rutgers Cancer Institute Rutgers RWJMedSchool Rutgers New Jersey Medical School

Please come and join our PGY4 resident Jongmyung Kim, MD PhD presenting his study on TP53 mutations in pancreatic cancer #ASTRO2022 ASTRO Rutgers Radiation Oncology Residency Program Rutgers Cancer Institute Rutgers RWJMedSchool Rutgers New Jersey Medical School

Please come and join our chief resident Imraan Jan presenting his study on ATM mutation in toxicity in breast cancer #ASTRO2022 ASTRO Rutgers Radiation Oncology Residency Program Rutgers Cancer Institute Rutgers RWJMedSchool Rutgers New Jersey Medical School

⁦Nadine Housri, MD⁩ from ⁦Yale University⁩ and our own ⁦Rutgers Radiation Oncology Residency Program⁩ graduate speaking at ⁦ASTRO⁩ annual meeting presidents symposium.

⁦Ron Ennis, M.D.⁩ from ⁦Rutgers Radiation Oncology Residency Program⁩ ⁦Rutgers Cancer Institute⁩ speaking at ⁦ASTRO⁩ annual meeting presidents symposium.

Dr. Jabbour Salma Jabbour Rutgers Radiation Oncology Residency Program Rutgers Cancer Institute now presenting in Lung 1 - Novel Prospective Radiation/Immunotherapy Combinations and Oligometastasis. #ASTRO22 ASTRO

#ASTRO2022 ASTRO Chair Howard Sandler ASTRO NRG/RTOG 1112: Randomized PhIII Study of Sorafenib vs. Stereotactic Body Radiation Therapy (SBRT) Followed by Sorafenib in Hepatocellular Carcinoma (HCC) showing OS and PFS benefit with SBRT+ sorafenib vs sorafenib alone. RTOG Foundation NRG Oncology

Our chief resident Dr. Imraan Jan Rutgers Radiation Oncology Residency Program Rutgers Cancer Institute now presenting his poster on “Clinical Toxicity in Hypofractionated and Conventionally Fractionated Radiation in Breast Cancer Patients with Germline ATM Mutations” #ASTRO22 ASTRO Bruce Haffty Jongmyung Kim, MD PhD

Dr. Haffty Bruce Haffty Department Chair Rutgers Radiation Oncology Residency Program Rutgers Cancer Institute now moderating in ASTRO Workforce Study: An Interim Report. #ASTRO22 ASTRO

Dr. Hathout Lara Hathout Rutgers Radiation Oncology Residency Program Rutgers Cancer Institute presenting in Overview of ASTRO's Radiation Therapy for Endometrial Cancer Guideline: a Multidisciplinary Case-based Interactive Discussion #ASTRO22 ASTRO

Awesome presentation by Jennifer Betourney !

Late night contouring buddy. 🐶

Rough life 🐶

Check this out our recent case report: A rare pattern of local recurrence in the nasopharyngeal carcinoma: Ca... sciencedirect.com/science/articl… Jongmyung Kim, MD PhD Missak Haigentz Suresh Mukherji Rutgers Radiation Oncology Residency Program Rutgers RWJMedSchool Rutgers Cancer Institute

Register today for the eContouring for Renal SBRT Webinar Tuesday 6/27 at 6 p.m. ET. This webinar offers a comprehensive review of radiation planning & hands-on contouring practice plus a live webinar with Q&A. ow.ly/I9mT50OPzpu Shankar Siva Nick Hardcastle

I’m always impressed by tv news people who can constantly talk for hours on election night. It’s very internal medicine of them.

US politics is so wild. Here's the Mayor of Knox County Tombstoning the US Secretary of Education

X-torial: Cleaning up the misinformation about Joe Biden and #ProstateCancer that I am reading everywhere. The purpose of this is to provide education from someone who treats and studies PCa for a living, lead the USA National Comprehensive Cancer Network (NCCN) PCa guidelines, hold leadership in NRG Oncology National Cancer Institute